Related Experiment Videos
[Cardiac pacing in obstructive hypertrophic cardiomyopathies]
L Kappenberger1, N Aebischer, X Jeanrenaud
1Division de Cardiologie, CHUV, Lausanne, Suisse.
Annales De Cardiologie Et D'Angeiologie
|December 1, 1994
Summary
Two-chamber pacemakers offer significant benefits for obstructive hypertrophic cardiomyopathy patients unresponsive to medication. This cardiac pacing improves hemodynamic and clinical outcomes by altering left ventricular activation and reducing outflow obstruction.
Area of Science:
- Cardiology
- Biomedical Engineering
Context:
- Obstructive hypertrophic cardiomyopathy (oHCM) traditionally managed with medication or surgery.
- Cardiac pacing's immediate effects on infra-aortic obstruction have been recognized.
- Advancements in pacemaker technology enable new therapeutic strategies.
Purpose:
- To evaluate the efficacy of two-chamber pacemakers in patients with obstructive hypertrophic cardiomyopathy.
- To explore the mechanisms behind the beneficial effects of cardiac pacing in oHCM.
Summary:
- Two-chamber pacemakers demonstrate significant hemodynamic and clinical improvements in oHCM patients.
- Mechanisms include altered left ventricular activation sequence and reduced septal contact.
- Long-term benefits may involve ventricular remodeling due to relief of outflow obstruction.
Impact:
- Cardiac pacing presents a viable alternative for drug-refractory oHCM cases.
- This approach warrants consideration for a broader patient population.
- Further research into pacing mechanisms can optimize treatment strategies.